Insulet | Операционный Доход



Operating Profit Изменить Дата
Abbott USD 2.07B 415M 2025-06
Align Technology USD 163.03M 31.93M 2025-06
AtriCure USD -3820000 2.13M 2025-06
Avanos Medical USD -53660000 63.96M 2025-06
Baxter International USD 272M 214M 2025-06
Becton, Dickinson and Co. USD 979M 433M 2025-06
Boston Scientific USD 942M 21M 2025-06
Cardinal Health USD 730M 181M 2025-03
Cooper Companies USD 184.8M 2.8M 2025-04
Dexcom USD 212.6M 78.9M 2025-06
Edwards Lifesciences USD 430.9M 36.1M 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
Globus Medical USD -125953000 222.96M 2025-06
ICU Medical USD 26.8M 2.78M 2025-06
Insulet USD 121.1M 71.8M 2025-06
Integra LifeSciences USD -1309000 14.65M 2025-06
J&J USD 6.94B 6.69B 2025-06
Masimo USD 64.5M 13.5M 2025-06
Medtronic USD 1.44B 210M 2025-04
Merit Medical Systems USD 47.02M 5.99M 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12
Solventum Corp 214M 62M 2025-06
Stryker USD 1.17B 331M 2025-06
Tandem Diabetes Care USD -31859000 89.02M 2025-06
Teleflex USD 177.48M 47.16M 2025-06
West Pharmaceutical Services USD 153.7M 46.7M 2025-06
Zimmer Biomet Holdings USD 396.4M 57.5M 2025-06


Insulet Операционный Доход - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Aug 2025.